Development and marketing of CATUVAB in Europe will be carried out by Lindis Blood Care. We are actively looking for international licensing partners to support our efforts outside of Europe.
Interested parties are welcome to contact us through our website.
The Next Step in
CATUVAB – a MEDICAL DEVICE to remove cancer cells from salvaged blood